# Ernexa Therapeutics Inc.: Form 8-K, filed May 27, 2022

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2022-05-27
- Accepted by EDGAR: May 27, 2022, 16:35 ET
- Period: 2022-05-24
- Accession: 0001140361-22-021033
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036122021033/brhc10038174_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036122021033/

## Items reported

- Item 3.01: Delisting notice
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036122021033/brhc10038174_8k.htm

Filed May 27, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-021033. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.
